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Introduction
Inflammation is an essential mechanism for restoring tissue integ-
rity after myocardial infarction (MI). After restriction of blood 
supply, the inflammatory response is characterized by a multistep 
cascade at both the cellular and molecular levels (1). Following 
an early accumulation of neutrophils, peripheral monocytes are 
attracted by various stimuli, enter the injured heart, and further 
amplify the inflammatory response (2, 3). After several days, the 
proinflammatory phase is superseded by a reparative phase in 
which monocyte-derived macrophages constitute the predomi-
nant immune cell type in the heart (4). These latter cells have a 
rather antiinflammatory program and provide a palette of medi-
ators that promote angiogenesis and collagen deposition, thereby 
contributing to the formation of a solid scar (5). Recent studies 
have shown that other leukocyte populations, such as DCs, mast 
cells, B cells, T cells, NK cells, and Tregs, also play important roles 
in MI healing (6–10). Despite their quantitative inferiority com-
pared with monocytes/macrophages at the site of inflammation, 
these cells either have direct potent effector functions or indi-
rectly coordinate the response of other immune cells. However, 
a more comprehensive characterization of cellular heterogeneity 
and interaction in the post-MI inflammatory network remains an 
important objective. A better understanding of how immune cells 
cooperate to restore tissue function and how the reaction of indi-
vidual cell types is integrated to yield a coordinated tissue-scale 
response following injury has important implications — not only 
for the identification of new cellular and molecular targets, but 
also for the successful implementation of promising immunomod-
ulatory therapies in patients with MI.
Basophils are blood-borne immune cells and were first 
described by Paul Ehrlich more than 130 years ago (11). The role 
of these cells in health and disease has long been an enigma, but 
research over the past 2 decades has shed more light on basophil 
biology (12). Basophils are conserved in all vertebrates, have a rel-
atively short lifespan of 2–3 days, and can be rapidly mobilized in 
inflammatory conditions (13). They express the high-affinity IgE 
receptor FcɛRI and can produce a set of defined effector mole-
cules, including proteolytic enzymes, bioactive lipids (prostaglan-
dins and leukotrienes), histamine, TNF-α, IL-6, IL-4, and IL-13. 
Basophils are best known to be critical effector cells in allergic 
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MI (21). Consistent with prior studies, the immune compartment 
in the infarcted myocardium consisted mainly of monocytes, mac-
rophages, DCs, B cells, T cells, and NK cells (Figure 1A). However, 
unbiased clustering of all leukocytes based on unique patterns of 
gene expression also indicated the presence of a basophil cluster 
marked by the expression of Mcpt8, which encodes mast cell prote-
ase 8 and other basophil markers (Figure 1A, Supplemental Figure 
1, A–C, and Supplemental Table 1; supplemental material available 
online with this article; https://doi.org/10.1172/JCI136778DS1). 
In order to corroborate whether the latter population in fact 
accumulates after myocardial ischemia, we studied infarcted 
hearts by flow cytometry. Basophils were identified as CD45int/hi 
Lin–CD117–CD49b+IgE+ cells (Figure 1B) (14). After permanent 
ligation of the left anterior descending artery (LAD), enumeration 
based on flow cytometry revealed an increase in basophil counts in 
infarcted hearts, with a peak occurring between days 3 and 7 and 
a return to baseline on day 14 (Figure 1C). Immunohistochemical 
staining confirmed the presence of Mcpt8+ cells in infarcted hearts 
(Figure 1D). Basophils express a variety of cytokine receptors and 
can therefore respond to numerous extrinsic signals that regulate 
their recruitment, degranulation, and cytokine production (22). 
Among the main mediators known for homing of basophils to 
inflamed tissue (IL-3, thymic stromal lymphopoietin, IL-33), we 
could identify IL-33 as a cytokine markedly upregulated in the 
reactions and protective immunity against parasites (14, 15). In 
addition, recent studies suggest that basophils are highly interac-
tive cells and may provide unique functions unmet by other hema-
topoietic cells, particularly in immune imprinting, host response 
to bacteria, autoimmune disease, and allograft fibrosis (16–20). 
Their role in cardiovascular diseases, however, has not been 
mechanistically explored to date.
In this study, we found that basophil counts increased in 
the infarcted myocardium within a few days after MI. With 
the use of antibody depletion and mice genetically deficient in 
basophils, we show that basophils were essential for competent 
MI healing, mainly by altering local monocyte/macrophage 
responses. Further, experiments in mice with basophil-specific 
IL-4/IL-13 deficiency indicated that these cytokines were essen-
tial mediators for basophil-dependent macrophage polarization 
after MI. These data provide insights into how basophils coordi-
nate innate immune responses during sterile inflammation and 
wound healing after MI.
Results
Basophil granulocytes infiltrate the heart after MI in mice. To exam-
ine the cellular composition of different immune cell types in MI 
healing, we performed an analysis of a single-cell RNA-Seq data 
set of cardiac leukocytes during the reparative phase after murine 
Figure 1. Basophil granulocytes infiltrate the heart after permanent LAD ligation in mice. (A) UMAP embedment of single-cell RNA-Seq data for cells 
isolated from the infarct region of a WT mouse heart 7 days after MI. (B) Representative images of flow cytometric analysis of heart tissue before and 
3 days after MI. SSC-W, side scatter pulse width. (C) Flow cytometric time course of Lin–CD45+CD117–CD49b+IgE+ cells after MI in WT mice (n = 3–6). Data 
show the mean ± SD. P values were determined by 1-way ANOVA with Sidak’s multiple-comparison post hoc test. (D) Immunohistochemical staining of 
Mcpt8+ cells (green, arrowhead) in the infarct region 7 days after MI. Nuclei are depicted in white (DAPI). Scale bar: 20 μm. Data show the mean ± SD.  
P value was determined by 2-tailed Student’s t test (n = 3).
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DCs between anti-FcεRI–treated mice and IgG control–treated 
mice (Supplemental Figure 2, E–I). Baseline left ventricular (LV) 
ejection fraction (EF) before surgery and initial infarct sizes on day 
1 as measured by cardiac troponin T (cTnT) levels in plasma sam-
ples and 2,3,5-triphenyltetrazolium chloride (TTC) staining were 
not different between the control and basophil-depleted mice 
(Figure 2, C and D, and Supplemental Figure 3A). Assessment of 
cardiac function 4 weeks after permanent LAD ligation confirmed 
reduced cardiac function and enlarged LV geometry accompanied 
by increased heart weight to body weight ratios in infarcted mice 
compared with animals after sham intervention. Basophil deple-
tion, however, led to larger end-diastolic and end-systolic volumes 
and a significant reduction of LV EF compared with isotype con-
trol–treated animals. In support of the observed reduced global 
contractility, we found a significantly greater decrease in global 
longitudinal strain in infarcted hearts of MAR-1–treated mice 
infarcted heart 2 days after MI with the correspondent receptor 
Il1rl1 expressed in the basophil cluster (Supplemental Figure 1, 
D and E). Furthermore, Ccl-5, IL-18, and IgE were significantly 
increased and may be additional stimuli for basophil recruitment 
and activation after MI (Supplemental Figure 1, F–K).
Antibody-mediated basophil depletion worsens cardiac function 
after acute MI. To clarify whether basophil accumulation into 
the infarcted myocardium was a mere bystander effect or had 
functional consequences, we depleted basophils by injecting the 
FcεRI-specific antibody MAR-1 (Figure 2A). As expected, anti-
FcεRI treatment almost completely abolished the number of baso-
phils in heart, peripheral blood, and spleen under basal conditions 
(Supplemental Figure 2A) and 2 days after permanent LAD liga-
tion (Figure 2B and Supplemental Figure 2, B–D). Mast cells and 
a subset of DCs also express the FcεRI, however, we detected no 
significant differences in the number of cardiac mast cells and 
Figure 2. Basophil depletion by antibody injection worsens cardiac function after acute MI in mice. (A) Timeline of basophil depletion experiments. (B) 
Frequencies of basophils from of hearts of IgG-injected control and anti-FcεRI–injected animals were assessed by flow cytometry 2 days (d2) after MI  
(n = 4). Data show the mean ± SD. P value was determined by 2-tailed Student’s t test. (C) Echocardiographic evaluation of baseline EF in IgG- and MAR-1–
treated mice. (D) Plasma levels of cTnT in IgG- and MAR-1–treated mice were measured 24 hours after LAD ligation or sham intervention. P values were 
determined by 2-way ANOVA followed by Tukey’s multiple-comparison test. (E–H) Echocardiographic results for IgG-treated and MAR-1–treated mice 4 
weeks after MI or sham surgery. P values were determined by 2-way ANOVA followed by Tukey’s multiple-comparison test. (I) Representative echocardio-
graphic images 4 weeks after MI. Vectors display the direction and magnitude of myocardial contraction at midsystole. (J) Quantification of heart weight 
to body weight ratio (HW/BW) determined 4 weeks after MI (n = 4–8). Data show the mean ± SD. P values were determined by 2-way ANOVA followed 
by Tukey’s multiple-comparison test. (K) Representative hearts from IgG- and MAR-1–treated mice 4 weeks after MI or sham intervention. Arrowheads 
indicate the site of ligation. Scale bars: 500 μm.
The Journal of Clinical Investigation R E S E A R C H  A R T I C L E
J Clin Invest. 2021;131(13):e136778  https://doi.org/10.1172/JCI1367784
Genetic basophil ablation alters myeloid cell responses following 
MI. To investigate the potential mechanism by which basophils 
contribute to myocardial healing, we studied the cellular inflam-
matory response in infarcted hearts in the presence and absence of 
basophils. In order to rule out potential off-target effects of baso-
phil depletion, we additionally established a restoration approach 
and transferred CD49b+ basophil-enriched splenocytes into Baso-
KO mice after MI in 1 group (Supplemental Figure 4, A–C). Flow 
cytometric analysis of murine hearts on day 4 after MI showed 
unaltered numbers of total CD45+ leukocytes and CD11b+ myeloid 
cells in all groups (Figure 4, A–C). However, subpopulation gating 
revealed a critically altered monocyte/macrophage response, with a 
significantly elevated presence of Ly6Chi inflammatory monocytes 
in the absence of basophils. Transfer of basophil-enriched cells into 
Baso-KO mice resulted in a reversal of the inflammatory phenotype 
observed in the absence of basophils (Figure 4, D and E). Monocyte 
levels in blood and bone marrow (BM) as well as vascular adhesion 
molecules (Vcam-1) in the heart were unchanged, indicating a local 
and heart-specific response independent of systemic monocytopoi-
esis (Figure 4, F and G, and Supplemental Figure 5A). Furthermore, 
Baso-KO mice showed a diminished ratio of antiinflammatory 
F4/80+CD206+ macrophages among cardiac F4/80+ macrophages 
compared with control animals (Figure 4, H and I). The findings 
were corroborated by significant changes in the transcriptional pro-
file of hearts from basophil-depleted mice characterized by upregu-
compared with the hearts of control-treated mice (Figure 2, E–I, 
and Supplemental Figure 3B). Additionally, MAR-1–treated mice 
showed increased heart weight to body weight ratios (Figure 2, J 
and K) and had significantly reduced scar thickness and increased 
LV lumen area (Supplemental Figure 3, C–E).
Mice with genetic basophil ablation show deteriorated healing 
after acute MI. Any antibody treatment may have limitations that 
influence healing processes, such as activation of the comple-
ment system, clearance of opsonized apoptotic cells, or pheno-
typical changes in cells expressing the antibody target (23). To 
overcome these limitations, we studied Mcpt8-Cre–transgenic 
(Baso-KO) mice that are constitutively deficient in basophils (14). 
Under basal conditions Baso-KO mice showed no cardiac-specific 
phenotype, as evaluated by echocardiography (Figure 3A). Upon 
LAD ligation, we detected no differences in initial infarct size as 
measured by cTnT levels in plasma samples 24 hours after infarc-
tion compared with WT mice (Figure 3B). However, 28 days after 
infarction, Baso-KO mice had developed severe cardiac dysfunc-
tion marked by significantly reduced LV EF, increased end-dia-
stolic and end-systolic LV volumes, decreased global longitudinal 
strain, and significantly increased heart weight to body weight 
ratios as compared with their WT littermates (Figure 3, C–G). His-
topathological evaluation, moreover, revealed significantly more 
LV chamber dilation and exaggerated scar thinning in Baso-KO 
mice compared with WT controls (Figure 3, H–K).
Figure 3. Baso-KO mice show deteriorated healing after MI. (A) Echocardiographic evaluation of baseline EF in WT and Baso-KO mice. (B) Plasma cTnT 
values in WT and Baso-KO mice measured 24 hours after LAD ligation. (C–F) Echocardiographic results for Baso-KO and WT mice 4 weeks after MI. P 
values were determined by 2-tailed Student’s t test. (G) Quantification of heart weight to body weight ratio 4 weeks after MI. P value was determined by 
2-tailed Student’s t test. (H and I) Scar thickness and LV lumen area were quantified by histological evaluation 4 weeks after MI (n = 6–8). Data show the 
mean ± SD. P values were determined by 2-tailed Student’s t test. (J and K) Representative echocardiographic and histological images of WT and Baso-KO 
mice 4 weeks after MI. 3D plots show radial displacement over 3 cardiac cycles. Histological sections were stained with Masson’s trichrome to detect fibro-
sis. Scale bars: 500 μm. Ant. sept., anterior septal; Post., posterior.
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respondent cytokine receptors were predominantly expressed in 
the monocyte/macrophage, DC, and CD4+ T cell clusters (Figure 
5D). Finally, multiplex immunohistochemistry corroborated IL-4–
expressing Mcpt8+ cells in close proximity to CD163+ macrophages 
(Supplemental Figure 5G). These findings suggest that basophils 
crucially affect cardiac IL-4 levels after MI, either by direct pro-
duction or indirectly through other local cytokine-producing cells.
Basophil-specific IL-4/IL-13 deficiency affects the cardiac immune 
response and aggravates cardiac dysfunction after MI. To directly 
assess the function of IL-4 and IL-13 derived from basophils, we 
exploited a previously established approach that allows the in vivo 
assessment of basophil-specific IL-4/IL-13 deletion (Supplemen-
tal Figure 6, A–J) (24). Following permanent LAD ligation, mice 
with basophils incapable of producing IL-4 or IL-13 showed sig-
nificantly higher levels of inflammatory Ly6Chi monocytes within 
the myeloid cell compartment in the infarcted heart, suggesting 
that the effect of basophils on monocytes/macrophages is main-
ly driven by basophil-derived IL-4 and IL-13 (Figure 6, A–C). The 
overall numbers of recruited CD45+ leukocytes and total CD11b+ 
myeloid cells remained unaltered (Supplemental Figure 6, K–M). 
lation of M1 markers (IL-12β, IFN-γ) and downregulation of the M2 
signature (arginase-1) (Supplemental Figure 5, B–D).
Basophils affect IL-4/IL-13 cytokine production in the injured 
heart after MI. To evaluate how basophils modulate monocytes/
macrophages, we next assessed the expression of different cyto-
kines and chemokines 3 days after MI. Among all tested cytokines 
that are known to be secreted by basophils (TNF-α, IL-6, IL-4, 
IL-13), only IL-4 was found to be significantly reduced in the heart 
of basophil-deficient mice 3 days after MI (Figure 5A). In addition, 
in the absence of basophils, we detected a significant reduction in 
the expression of histidine decarboxylase (Hdc), which catalyzes 
the decarboxylation of histidine to form histamine (Supplemental 
Figure 5, E and F). To further evaluate these results, we used Baso-
KO and WT mice on a 4get background, in which all IL-4+ cells 
express GFP. Similar to the findings described above, on the mRNA 
level, the number of GFP+ cells after MI was markedly reduced in 
the hearts of Baso-KO 4get mice compared with control mice (Fig-
ure 5, B and C). Gene expression analysis of single-cell RNA-Seq 
data, moreover, confirmed that IL-4 and IL-13 were detectable 
mainly in the basophil cluster, whereas genes encoding the cor-
Figure 4. Genetic basophil depletion affects cardiac monocytes and macrophages. (A) Representative flow cytometric plots of infarct tissue 4 days after 
MI, following transfer of basophil-enriched cells (bottom) gated on monocytes/macrophages. Heart cells were from WT and Baso-KO mice, and splenic 
cells were from WT mice. (B and C) Quantification of total numbers of CD45+ cells or CD45+CD11b+ cells per milligram of heart tissue. (D and E) Percentage 
of heart-infiltrating Ly6Chi monocytes and Ly6CloCD64+ macrophages (among the percentage of total Lin–CD11b+ cells) 4 days after LAD ligation (n = 8–9). 
Data indicate the mean ± SD. P values were determined by 1-way ANOVA followed by Tukey’s multiple-comparison test. (F and G) Blood and BM monocyte 
levels for the indicated groups 4 days after MI (n = 6). (H) Representative histogram depicting CD206+ cells among Lin–CD11b+F4/80+ macrophages 4 days 
after MI. (I) Proportion of CD206+ cells among Lin–CD11b+F4/80+ macrophages in the heart 4 days after MI (n = 7). Data show the mean ± SD. P value was 
determined by 2-tailed Student’s t test.
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Furthermore, basophil-specific IL-4/IL-13 deficiency exacerbat-
ed cardiac dysfunction and resulted in a more pronounced infarct 
expansion and thinner infarct thickness compared with control 
mice 28 days after MI (Figure 6, D–K).
IL-4 induction in basophils by IPSE/α-1 improves heart function 
after MI. Given the finding that the absence of basophils impeded 
the post-MI healing process, we hypothesized that activation of 
basophils and their production of IL-4/IL-13 may enhance myo-
cardial healing and improve heart function following cardiac inju-
ry. Helminth parasites are known to be potent natural inducers of 
Th2 cytokines, and it was previously shown that IPSE/α-1, a major 
secretory product from Schistosoma mansoni eggs, can trigger 
basophils to release IL-4 and IL-13 (25, 26). As expected, in vitro 
stimulation of human basophils purified from healthy donors with 
IPSE/α-1 with or without IL-33 supplementation led to a robust 
release of IL-4 and IL-13 (Supplemental Figure 7, A and B). More-
over, supernatant from IPSE/α-1–treated basophils significantly 
increased the expression of CD206 and CD209 on monocytes 
compared with supernatant from control-treated basophils (Sup-
plemental Figure 7, C and D). In vivo, post-MI administration of 
IPSE/α-1 resulted in significantly increased levels of cardiac IL-4 
compared with PBS-treated controls (Figure 7, A and B). Further, 
IPSE/α-1–treated animals showed significantly improved cardiac 
function and cardiac remodeling 28 days after MI compared with 
control-treated animals, despite equal initial infarct sizes. These 
positive effects were lost upon additional administration of anti-
FcεRI antibody, indicating a basophil-dependent mechanism of 
IPSE/α-1 (Figure 7, C–G, and Supplemental Figure 7, E and F).
Low basophil counts are associated with poor outcomes for 
patients with acute MI. Finally, we addressed the relevance of 
these findings for patients with MI. We performed flow cytometric 
staining of human basophils and prospectively performed analy-
ses of blood from patients presenting with acute MI (n = 11) and 
controls with nonischemic cardiovascular disease (n = 9) (Figure 
8A and Supplemental Table 2). Initial blood basophil counts of 
patients with MI (0 h) were in the same range as those of control 
patients. Interestingly, however, we found that basophil counts 
gradually increased in subsequent days, reaching a maximum 96 
hours after MI (Figure 8B). Furthermore, we detected significantly 
higher expression of CD63, a human basophil activation marker, 
on circulating basophils 48 hours after MI compared with control 
basophils, suggesting functional differences as well (Figure 8C). 
To explore the potential contribution of basophils to the outcome 
of human MI healing, we prospectively assessed the association 
of blood basophil counts during acute MI healing and clinical out-
comes in an additional cohort of 82 patients. The patients’ base-
Figure 5. Basophils contribute to IL-4 and IL-13 production in the injured heart after MI. (A) mRNA expression of Il6, Tnfa, Il4, and Il13 in the infarct region 
3 days after MI in WT and Baso-KO mice (n = 8–9). mRNA levels are expressed as x-fold relative to the WT MI group. Data show the mean ± SD. P values 
were determined by 2-way ANOVA followed by Sidak’s multiple-comparison test. (B) Representative flow cytometric plots of cells from the infarct region 3 
days after MI in WT 4get and Baso-KO 4get mice. (C) Quantification of GFP+ cells in the infarct region 3 days after MI in control WT 4get and Baso-KO 4get 
mice (n = 5). Data show the mean ± SD. P value was determined by 2-tailed Student’s t test. (D) Gene expression dot plot based on single-cell RNA-Seq 
analysis of mouse cardiac leukocytes 3–7 days after MI. Mean expression is depicted by color intensity, whereas the dot size represents the fraction of cells 
expressing the indicated gene.
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line characteristics are provided in Supplemental Table 3. Using 
linear regression analyses, we found that besides known risk fac-
tors, such as initial infarct size or inflammatory levels, low num-
bers of basophils in blood during the first week after MI correlated 
significantly with a larger scar size, quantified by late gadolinium 
enhancement (LGE) cardiac MRI after 1 year of follow-up (R2 = 
0.1224, P = 0.0013) (Figure 8, D–G, and Supplemental Table 4). 
Critically, this association persisted after adjustment of potential 
confounders, including initial infarct size, systemic inflammatory 
levels, and cardiovascular risk factors by multivariate regression 
analysis (Supplemental Table 5).
Discussion
Basophils are rare cells best known for their activity in allergic 
reactions and parasitic infections. Our knowledge about their 
function in the progression of cardiovascular diseases, however, 
is limited. Here, we report that basophils played an important role 
in regulating the post-MI immune response. Our in vivo studies 
indicated that the absence of basophils worsens the outcome after 
MI through an altered monocyte/macrophage response. Mono-
cytes and monocyte-derived macrophages constitute the largest 
leukocyte subpopulations in the heart during the first days after 
cardiac ischemia and greatly affect adverse remodeling (27). 
Notably, we found that the absence of basophil accumulation sub-
stantially reduced the levels of IL-4/IL-13, which are prototypical 
type 2 cytokines and generally considered to have antiinflamma-
tory properties. IL-4 and IL-13 are known to induce phenotypical 
and functional changes within macrophages, which can then be 
characterized by high expression of classical antiinflammatory 
and tissue repair genes, such as Arg1, Mrc1 (CD206), or Retnla 
(28). Systemic IL-4 administration after MI was previously shown 
to reduce infarct size and enhance tissue repair, mainly through 
the augmentation of reparative macrophages (29, 30). IL-13 is also 
crucially involved in infarct healing, as genetic IL-13 deficiency 
worsens post-MI outcomes in adult mice (31).
Having shown that the absence of basophils significantly low-
ered IL-4/ IL-13 in the heart after MI, we next assessed the extent 
to which basophil-derived IL-4/IL-13 might be important in vivo. 
To do this, we generated mice with basophils lacking IL-4/IL-13. 
Basophil-specific IL-4/IL-13 deficiency recapitulated the altered 
monocyte/macrophage response and LV impairment previously 
observed in basophil-depleted mice. Yet, we cannot exclude the 
possibility that additional factors other than IL-4/IL-13 might 
contribute to the polarizing effects of basophils on macrophages. 
Figure 6. Basophil-specific IL-4/IL-13 
depletion alters healing after MI. (A 
and B) Percentage of cardiac Ly6Chi 
monocytes and Ly6Clo macrophages 
(among the percentage of total Lin–
CD11b+ cells) 4 days after MI (n = 8–9). 
Data show the mean ± SD. P values 
were determined by 2-tailed Student’s t 
test. (C) Representative flow cytometric 
plots of cells from infarct tissue 4 days 
after MI in BasoWT and Baso4-13KO mice 
gated on monocytes/macrophages. (D 
and E) Echocardiographic evaluation 
of baseline EF and plasma cTnT levels 
24 hours after LAD ligation in BasoWT 
and Baso4-13KO mice. (F) Representative 
echocardiographic images of mice from 
the indicated groups on day 1 and day 
28 after MI. (G–I) Echocardiographic 
results for BasoWT and Baso4-13KO mice 4 
weeks after MI (n = 6–8). Data show the 
mean ± SD. P values were determined 
by 2-tailed Student’s t test. (J) Quanti-
fication of LV scar thickness based on 
histological evaluation 4 weeks after 
MI (n = 6–8). Data show the mean ± 
SD. P value was determined by 2-tailed 
Student’s t test. (K) Representative 
images of histological sections stained 
with Masson’s trichrome 4 weeks after 
MI. Scale bars: 500 μm.
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FcεRI and triggers the release of IL-4 and IL-13, thereby contrib-
uting to inflammation control in the host (38, 39). We evaluated 
whether these effects could also affect inflammation after cardi-
ac ischemia and found beneficial effects upon administration of 
IPSE/α-1. Of note, the treatment was initiated after the infarct, 
which might suggest translational potential. Since basophil deple-
tion reversed the improved outcome after the IPSE/α-1 regimen, 
we conclude that the protective effects were mediated primari-
ly through the basophil IL-4/IL-13 axis. However, we cannot 
exclude the possibility that additional beneficial systemic effects 
might also have contributed to this protection, e.g., as it was 
recently shown that IPSE/α-1 can also trigger the development 
of regulatory B cells and their release of IL-10, or IPSE/α-1 might 
affect mast cells via FcεRI signaling (40). Of note, we found that 
IgE/FcεRI signaling was regulated after experimental MI in mice, 
even without IPSE/α-1 treatment, which was observed previously 
in patients with MI and might therefore be an interesting investi-
gative target for future studies (41). Since these observations on 
upstream mechanisms for basophil activation and recruitment 
after MI are so far correlative, they will require further mechanis-
tic validation in the future.
Our present study indicates that basophils have distinct kinet-
ics in the blood in patients after ST-elevation MI (STEMI) and 
that an inadequate basophil response in humans correlates with 
impaired remodeling after acute MI. In contrast to our experiments 
in mice, however, no causative conclusions can be drawn regarding 
In addition, it is conceivable that basophil-derived IL-4 and IL-13 
might also trigger the release of factors by macrophages them-
selves that promote their own phenotypic switch. Recently, it was 
shown that deficiency of IL-4 and IL-13 in hepcidin-deficient mac-
rophages hampered tissue repair after MI, suggesting that macro-
phages (especially CD206+ macrophages) are able to release IL-4 
and IL-13 in the injured myocardium (32). Skewing themselves 
and neighboring macrophages toward a reparative phenotype via 
an autocrine/paracrine IL-4/IL-13 loop might be an additional 
mechanism for potentiating the effect of basophil-secreted IL-4 
and IL-13. Finally, it should be noted that, apart from IL-4 and 
IL-13, other mechanisms have been described to be involved in 
macrophage polarization and fate specification after MI (33–36). 
It is tempting to speculate that some of these signals synergize 
with IL-4 and IL-13 to cooperatively induce antiinflammatory 
macrophage polarization. Interestingly, it has been shown that 
IL-4 and IL-13 require the presence of apoptotic and necroptotic 
cells to induce an antiinflammatory program in macrophages after 
microbial infection (19, 37). Further investigations will be required 
to fully decrypt how the different signals are integrated at cellular 
and molecular levels for post-MI macrophage reprogramming.
Parasites, and in particular schistosomes, have potent mod-
ulatory effects on the immune system by inducing robust type 2 
immune responses. The major secreted product of schistosome 
eggs is the glycoprotein IPSE/α-1 (25). IPSE/α-1 activates baso-
phils by antigen-independent binding to IgE molecules on the 
Figure 7. IPSE/α-1 enhances cardiac IL-4 and improves heart function after MI. (A) Timeline of experimental setting for the treatment of infarcted 
mice with IPSE/α-1 or PBS, respectively. (B) mRNA expression of Il4 in the infarcted region of hearts from PBS- or IPSE/α-1–treated mice 3 days after 
MI. Data were pooled from 2 independent experiments (n = 6–8) and show the mean ± SD. P value was determined by 1-way ANOVA with Sidak’s mul-
tiple-comparison test. (C) cTnT levels 1 day after LAD ligation. (D–F) Echocardiographic results for mice treated with either PBS, IPSE/α-1, or IPSE/α-1 
plus MAR-1 twenty-eight days after MI (n = 6–12). Data show the mean ± SD. P values were determined by 1-way ANOVA with Tukey’s multiple-compar-
ison test. (G) Representative echocardiographic images of parasternal long-axis (left) and short-axis (right) views in mice from the indicated groups 4 
weeks after experimental MI.
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(14), IL-4eGFP reporter (4get) mice (42), and IL-4/IL-13–deficient 
mice (43) have been previously described. Animals were housed under 
standard laboratory conditions with a 12-hour light/12-hour dark cycle 
and ad libitum access to water and food.
Generation of mixed BM chimeras. BM cells were obtained from 
tibiae and femurs of Baso-KO mice and mixed at a 4:1 ratio with BM 
cells from either WT mice or IL-4/IL-13–deficient mice (24). Cells (2 × 
106) were injected into the tail vein of lethally irradiated (9 Gy) recipi-
ent C57BL/6 mice to create BasoWT and Baso4-13KO mixed BM chimeras 
(MBMCs), respectively. Mice were given antibiotic-containing drink-
ing water (2 g/L neomycin sulfate, 100 mg/L polymyxin B 328 sulfate; 
MilliporeSigma) for 8 weeks after reconstitution.
Induction of MI. MI was induced by permanent ligation of the LAD 
as described previously (35). In brief, anesthesia was induced with iso-
flurane (4%/800 mL O2/min) and maintained by endotracheal ven-
tilation (2%–3%/800 mL O2/min). A thoracotomy was performed in 
the fourth left intercostal space. The left ventricle was exposed, and 
the left coronary artery was permanently occluded. The chest and 
skin were closed, and anesthesia was terminated. The animals were 
extubated when their breathing was restored. Initial myocardial injury 
was evaluated by measuring cTnT levels in plasma 24 hours after MI 
induction. Valid myocardial injury was defined as a cTnT level above 
5000 pg/mL. Sham-operated animals underwent the same procedure 
except for the LAD occlusion.
Basophil depletion and basophil-specific IL-4 induction. For deple-
tion of basophils, 10 μg anti-FcεRI antibody (eBiosciences, clone 
the association between basophil numbers and cardiac outcomes 
in humans. Further, we recognize that basophil kinetics including 
phenotypical changes in humans might be at least partially influ-
enced by (so-far-unknown) effects of post-MI therapeutic regi-
mens. It seems possible that IL-4/IL-13–driven pathologies such 
as atopic dermatitis and allergic asthma, but also their treatment, 
may interfere with the healing process after MI. This is of particu-
lar interest, as a growing number of patients will receive biological 
agents that interfere with the IL-4/IL-13 axis (e.g., the monoclo-
nal antibody dupilumab). Further mechanistic studies are needed 
to identify possible interlinks and delineate the protective versus 
rather harmful effects of these conditions on post-MI healing.
In summary, we have identified an unexpected role for baso-
phils in the context of MI healing. Despite their low numbers, 
we found that basophils strongly affected accumulating myeloid 
cells by releasing IL-4 and IL-13 and thereby influencing cardiac 
remodeling. More broadly, these findings provide insights into 
how basophils and basophil-derived cytokines control temporal 
and spatial containment of sterile inflammation. The use of baso-
phils as regulators in Th1-driven pathologies might be a promising 
immune-modulatory therapeutic strategy for exaggerated acute 
or chronic inflammation.
Methods
Animals. All mice were on a C57BL/6J background and were studied 
at 8–10 weeks of age. Basophil-deficient Mcpt8-Cre (Baso-KO) mice 
Figure 8. Low basophil counts predict poor remodeling in patients with STEMI. (A) Gating strategy for the identification of blood basophils in patients 
with STEMI. (B) Kinetics of blood basophils identified as CD45+CD19–CD3–CD117–FcεRI+CD203c+ in patients with STEMI (n = 11) and control patients  
(n = 9). P values were determined by 1-way ANOVA with Sidak’s multiple-comparison test. (C) Quantification of CD63 expression on human basophils 
based on MFI for control and MI patients. Data show the mean ± SD. P value was determined by 2-tailed Student’s t test. (D–G) Linear regression analysis 
for the association of scar size 12 months after MI and maximum (max) basophil counts during the first week after MI (D), cTnT levels 24 hours after MI (E), 
peak CRP values (F), and peak leukocyte counts (G) during the first week after MI. Curved blue lines indicate 95% CIs. Each data point (n = 82) represents a 
biologically independent sample.
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Opal fluorophores from the Opal 7-Color Fluorescent IHC Kit (Perkin-
Elmer) were used. DAPI was used for nuclear visualization, and slides 
were mounted with Fluoromount-G (SouthernBiotech). Images were 
acquired using the Vectra Polaris automated imaging system at ×20 
resolution. Images were analyzed using Inform software, version 2.4 
(Akoya Biosciences) and quantified using QuPath (46).
Flow cytometry. Peripheral blood was collected by facial vein 
puncture in heparinized tubes, and erythrocytes were lysed in RBC 
lysis buffer (Miltenyi Biotec). Hearts, spleens, and BM were har-
vested after cervical dislocation. Single-cell suspensions of BM 
were obtained by flushing 1 dissected femur with 2 mL ice-cold PBS 
(MilliporeSigma). Single-cell suspensions of infarcted hearts were 
obtained by mincing the tissue with fine scissors and digesting it with 
a solution containing 450 U/mL collagenase I, 125 U/mL collagenase 
XI, 60 U/mL DNase I, and 60 U/mL hyaluronidase (MilliporeSigma) 
for 1 hour at 37°C while shaking. Absolute cell numbers were counted 
in a Neubauer chamber. Cells (10 × 106) were stained for flow cyto-
metric analysis. The fluorescent antibodies and corresponding gating 
strategies used are described in the Supplemental Methods. Flow 
cytometry was performed on a FACSVerse (BD Biosciences). Data 
were analyzed using FlowJo software.
Quantitative real-time PCR. Total RNA was isolated from cardiac 
tissue using TRIzol Reagent (Thermo Fischer Scientific) following the 
manufacturer’s instructions. RNA was reverse transcribed using the 
Revert Aid First Strand cDNA Synthesis Kit (Thermo Fisher Scientif-
ic). Quantitative real-time PCR (RT-qPCR) was performed using SYBR 
Green (Bio-Rad Laboratories) according to the manufacturer’s instruc-
tions. Relative changes were normalized to 18s mRNA using the 2 ΔΔCt 
method. mRNA levels are expressed relative to the indicated control 
conditions (set to 1). All primers are listed in the Supplemental Methods.
In silico analysis of single-cell RNA-Seq. The ArrayExpress data set 
E-MTAB-7376 was examined. This data set contains sequencing data 
from nonmyocytic cells isolated from hearts on days 3 and 7 after per-
manent ligation of the LAD (21). Analysis was performed using the 
Python package Scanpy (47). Only cells with more than 200 expressed 
genes and a mitochondrial content of less than 10% were considered. 
Genes that were expressed in fewer than 3 cells were also filtered out. 
The data were log-normalized to a scale factor of 10,000. Only high-
ly variable genes were considered for linear dimensional reduction 
and were defined by a minimum mean expression of 0.0125, a max-
imum mean expression of 3, and a minimum dispersion of 0.5. The 
effects of total counts and mitochondrial content were regressed out. 
The dimensionality reduction was done using principal component 
analysis (PCA). The neighborhood graph was computed using the 
UMAP algorithm for the first 50 principal components (n_PC = 50). 
Unsupervised clustering was performed using the Leiden algorithm. 
Differentially expressed genes were calculated for each cluster using 
the Wilcoxon rank-sum test. Clusters enriched for leukocyte markers 
were selected. This leukocyte subpopulation was then reanalyzed for 
day 7 (n_PC = 20) and a combination of days 3 and day 7 (for evalua-
tion of cytokine/cytokine receptor expression; n_PC = 40) for differ-
ent cell types as described above, and each cluster was annotated to 
a specific cell type.
Population of patients with acute MI. Blood samples from 11 con-
secutive patients with acute STEMI and 9 matched control patients 
with nonischemic cardiovascular disease were analyzed by flow 
cytometry. All patients with MI had been treated by percutaneous 
MAR-1) was injected i.p. on pre-MI days –3, –2, and –1 and repeated 
on post-MI days 1 and 5 in order to maintain reduced levels during 
the first 7 days after MI. IPSE/α-1 was expressed in human embryonic 
kidney (HEK) cells and purified from culture supernatant as described 
previously (44). Mice were then injected i.v. with 25 μg IPSE/α-1 or 
saline on post-MI days 1, 2, 3, 4, and 5.
Adoptive transfer of basophil-enriched cells. Adoptive transfer of 
basophil-enriched cells was performed by combining 2 previously 
published methods (15, 20, 45). In detail, donor WT mice were injected 
i.v. with a combination of 10 μg mouse recombinant IL-3 (Peprotech) 
and 5 μg anti–IL-3 antibody (BD Biosciences, clone MP2-8F8) in 200 
μL PBS 3 days before euthanasia in order to increase the basophil frac-
tion within these mice. At necropsy, single-cell suspensions of spleens 
were prepared, and the basophil-enriched CD49b+ fraction was iso-
lated using PE-conjugated anti–NK-1.1 antibodies (BD Biosciences, 
clone PK136) and anti-phycoerythrin (anti-PE) MicroBeads (Miltenyi 
Biotec) for negative selection and anti-CD49b MicroBeads (Miltenyi 
Biotec, clone DX5) for positive selection. Cells (1.0 × 106) were resus-
pended in 200 μL DMEM and transferred into Baso-KO mice i.v. on 
days 1, 2, and 3 after experimental MI.
Echocardiographic measurements. Echocardiography was per-
formed on a Vevo 2100 (VisualSonics). Mice were conscious during 
the echocardiographic measurements. Left parasternal long-axis 
and left mid-papillary views were acquired. LV end-diastolic volume, 
end-systolic volume, and EF were evaluated on the left parasternal 
long-axis view using VevoLab software (VisualSonics). Longitudinal 
LV global strain was quantified in the longitudinal axis by speckle 
tracking using VevoStrain software (VisualSonics). Infarct expansion 
was quantified semiautomatically by analyzing regional displacement 
in the parasternal long axis using VevoStrain software. The infarct 
region was defined as the percentage of LV area with a displacement 
of less than 0.1 during mid-systole relative to the global LV circumfer-
ence (49 LV spots). Infarct expansion was defined as Δ = infarct region 
(day 28) – infarct region (day 1). Investigators were blinded to the sam-
ple group allocation during the experiments and analyses.
Histopathological analysis. Post-MI cardiac healing was assessed 
on day 28. For paraffinized sections, hearts were excised, rinsed in 
PBS, and fixed for 1–3 days in 10% buffered formalin at 4°C. Hearts 
were then dehydrated, paraffinized, and sectioned (4–6 μm). For cryo-
sections, hearts were excised, rinsed in PBS, fixed for 3 hours in 4% 
PFA at room temperature, and stored overnight in 30% sucrose at 4°C. 
Hearts were embedded in Tissue-Tek OCT compound (Sakura) and 
sectioned (9 μm thickness). Tissue sections were then stained with the 
Masson’s Trichrome Stain Kit (MilliporeSigma) according to the man-
ufacturer’s instructions. ImageJ software (NIH) was used to analyze 
the fibrotic area. Scar thickness was averaged from 5 measurements at 
1 mm intervals from the ligature site to the apex in both long and short 
axes in a blinded fashion.
Multiplex immunohistochemical analysis. Multiplex immunohis-
tochemical stainings of 4 μm sections from murine infarcted hearts 
or healthy specimens were performed using the BOND RX Research 
Stainer (Leica Biosystems) with antibodies against Mcpt8 (BioLeg-
end, clone TUG8, 1:100 dilution), IL-4 (BioLegend, clone 11B11, 1:250 
dilution), CD163 (Abcam, clone EPR19518, 1:100 dilution), and IgE 
(BioLegend, clone RME-1, 1:250 dilution) according to the manufac-
turer′s instructions. Recommended solutions from the Opal Polaris 
Color Automation IHC Detection Kit (Akoya Biosciences) as well as 
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2 groups were performed using an unpaired, 2-tailed Student’s t test 
after passing normal distribution testing. Differences between more 
than 2 groups were analyzed by 1-way or 2-way ANOVA followed by 
Tukey’s or Sidak’s post hoc test. A P of less than 0.05 was considered 
statistically significant. All data are expressed as the mean ± SD.
Study approval. All animal procedures were approved by the IRB 
of the University of Heidelberg and the responsible government 
authority (Regierungspräsidium Karlsruhe of the state of Baden-Würt-
temberg, Karlsruhe, Germany; project nos. G-318/14 and G-43/17). 
Human studies were conducted according to Declaration of Helsinki 
principles and were approved by the local ethics commission (Ethik-
kommission der Medizinischen Fakultät Heidelberg, Heidelberg, Ger-
many). Written informed consent was obtained from all patients.
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coronary intervention (PCI) and stenting within a median of 3 hours 
of symptom onset. Heparinized blood was lysed using BD FACS 
lysing solution (BD Biosciences) according to the manufacturer’s 
instructions. The following fluorescent antibodies were used for 
staining and flow cytometric analysis: anti–CD45-FITC (BioLegend, 
clone HI30), anti–CD19-APC-Cy7 (BioLegend, clone HIB19), anti–
CD3-Percp-Cy5.5 (BioLegend, clone UCHT1), anti–CD117-PE-Cy7 
(BioLegend, clone 104D2), anti–FcεRI-PE (BioLegend, clone AER-
37), anti–CD203c-APC (BioLegend, clone NP4D6), and anti–CD63-
BV421 (BioLegend, clone H5C6). Human basophils were identified 
as CD45+CD19–CD3–CD117–FcεRI+CD203c+ cells (48). Flow cytome-
try was performed on a FACSVerse flow cytometer (BD Biosciences). 
Data were analyzed using FlowJo software. Another 82 patients with 
acute MI were separately considered in our observational follow-up 
study. Patients who presented with acute STEMI at the chest pain unit 
of the University Hospital of Heidelberg were included from Novem-
ber 2010 until January 2020. All patients underwent PCI and stenting 
and were treated according to European Society of Cardiology (ESC) 
guidelines, which included administration of aspirin, P2Y12 antago-
nists, heparin, morphine, beta blockers, statins, and — if the EF was 
lower than 55% — angiotensin-converting enzyme (ACE) inhibitors 
or AT1 antagonists, as well as mineralocorticoid antagonists for 
heart failure therapy. Patients undergoing immunosuppressive ther-
apy were excluded from the analysis. Basophils were counted on an 
ADVIA 2120i hematology system (Siemens) using the basophil/lobu-
larity method, which allows valid identification of basophils in human 
blood. Heart characteristics were determined by cardiac magnetic 
resonance (CMR) 12 months after the initial event. The association of 
each covariate with the dependent variable was assessed with a uni-
variate linear regression model. Bonferroni’s correction was used to 
adjust the P values for multiple testing. The covariates are listed in 
Supplemental Table 4 and included maximum basophil counts, cTnT 
levels 24 hours after MI, as well as maximum peripheral leukocyte 
counts and serum C-reactive protein (CRP) values during the first 
week after MI. Multivariate regression analysis was performed after 
computed variable selection. In detail, all variables with a P value of 
greater than 0.5 in the univariate linear regressions were excluded. 
Then, backward selection was performed, and the variable with the 
highest P value was excluded. The backward steps were repeated 
until all included variables were significant (P < 0.05).
Statistics. Statistical analyses were performed using GraphPad 
Prism, version 8 (GraphPad Software). Endpoint comparisons between 
 1. Frangogiannis NG. The inflammatory response in 
myocardial injury, repair, and remodelling. Nat 
Rev Cardiol. 2014;11(5):255–265.
 2. Horckmans M, et al. Neutrophils orchestrate 
post-myocardial infarction healing by polarizing 
macrophages towards a reparative phenotype. 
Eur Heart J. 2017;38(3):187–197.
 3. Bajpai G, et al. Tissue resident CCR2– and 
CCR2+ cardiac macrophages differentially 
orchestrate monocyte recruitment and fate spec-
ification following myocardial injury. Circ Res. 
2019;124(2):263–278.
 4. Hilgendorf I, et al. Ly-6Chigh monocytes depend 
on Nr4a1 to balance both inflammatory and 
reparative phases in the infarcted myocardium. 
Circ Res. 2014;114(10):1611–1622.
 5. Libby P, et al. Leukocytes link local and systemic 
inflammation in ischemic cardiovascular dis-
ease: an expanded “cardiovascular continuum.”  
J Am Coll Cardiol. 2016;67(9):1091–1103.
 6. Hofmann U, et al. Activation of CD4+ T lympho-
cytes improves wound healing and survival after 
experimental myocardial infarction in mice. Cir-
culation. 2012;125(13):1652–1663.
 7. Weirather J, et al. Foxp3+ CD4+ T cells improve 
healing after myocardial infarction by modulat-
ing monocyte/macrophage differentiation. Circ 
Res. 2014;115(1):55–67.
 8. Zouggari Y, et al. B lymphocytes trigger mono-
cyte mobilization and impair heart function 
after acute myocardial infarction. Nat Med. 
2013;19(10):1273–1280.
 9. Ngkelo A, et al. Mast cells regulate myofila-
ment calcium sensitization and heart func-
tion after myocardial infarction. J Exp Med. 
2016;213(7):1353–1374.
 10. Anzai A, et al. Regulatory role of dendritic cells in 
postinfarction healing and left ventricular remod-
eling. Circulation. 2012;125(10):1234–1245.
 11. Ehrlich P. Ueber die specifischen Granulationen 
des Blutes. Archiv fuer Anatomie und Physiologie: 
Physiologische Abteilung. 1879;571–579.
 12. Sullivan BM, Locksley RM. Basophils: a nonre-
dundant contributor to host immunity. Immunity. 
2009;30(1):12–20.
 13. Voehringer D. Protective and pathological roles 
of mast cells and basophils. Nat Rev Immunol. 
2013;13(5):362–375.
The Journal of Clinical Investigation R E S E A R C H  A R T I C L E
J Clin Invest. 2021;131(13):e136778  https://doi.org/10.1172/JCI1367781 2
 14. Ohnmacht C, et al. Basophils orchestrate chronic 
allergic dermatitis and protective immunity 
against helminths. Immunity. 2010;33(3):364–374.
 15. Wada T, et al. Selective ablation of basophils 
in mice reveals their nonredundant role in 
acquired immunity against ticks. J Clin Invest. 
2010;120(8):2867–2875.
 16. Charles N, et al. Basophils and the T helper 2 
environment can promote the development of 
lupus nephritis. Nat Med. 2010;16(6):701–707.
 17. Cohen M, et al. Lung single-cell signaling inter-
action map reveals basophil role in macrophage 
imprinting. Cell. 2018;175(4):1031–1044.
 18. Schiechl G, et al. Basophils trigger fibroblast acti-
vation in cardiac allograft fibrosis development. 
Am J Transplant. 2016;16(9):2574–2588.
 19. Bleriot C, et al. Liver-resident macrophage necro-
ptosis orchestrates type 1 microbicidal inflam-
mation and type-2-mediated tissue repair during 
bacterial infection. Immunity. 2015;42(1):145–158.
 20. Piliponsky AM, et al. Basophil-derived tumor 
necrosis factor can enhance survival in a sepsis 
model in mice. Nat Immunol. 2019;20(2):129–140.
 21. Farbehi N, et al. Single-cell expression profiling 
reveals dynamic flux of cardiac stromal, vascular 
and immune cells in health and injury. Elife. 
2019;8:e43882.
 22. Voehringer D. Basophil modulation by cytokine 
instruction. Eur J Immunol. 2012;42(10):2544–2550.
 23. Dunkelberger JR, Song WC. Complement and its 
role in innate and adaptive immune responses. 
Cell Res. 2010;20(1):34–50.
 24. Schwartz C, et al. Basophil-mediated protection 
against gastrointestinal helminths requires 
IgE-induced cytokine secretion. Proc Natl Acad 
Sci U S A. 2014;111(48):E5169–E5177.
 25. Schramm G, et al. IPSE/alpha-1: a major 
immunogenic component secreted from Schis-
tosoma mansoni eggs. Mol Biochem Parasitol. 
2006;147(1):9–19.
 26. Schramm G, et al. Molecular characteriza-
tion of an interleukin-4-inducing factor from 
Schistosoma mansoni eggs. J Biol Chem. 
2003;278(20):18384–18392.
 27. Leuschner F, Nahrendorf M. Novel functions of 
macrophages in the heart: insights into electrical 
conduction, stress, and diastolic dysfunction. Eur 
Heart J. 2020;41(9):989–994.
 28. Van Dyken SJ, Locksley RM. Interleukin-4- and 
interleukin-13-mediated alternatively activated 
macrophages: roles in homeostasis and disease. 
Annu Rev Immunol. 2013;31:317–343.
 29. Shiraishi M, et al. Alternatively activated macro-
phages determine repair of the infarcted adult 
murine heart. J Clin Invest. 2016;126(6):2151–2166.
 30. Shintani Y, et al. IL-4 as a repurposed biological 
drug for myocardial infarction through augmen-
tation of reparative cardiac macrophages: proof-
of-concept data in mice. Sci Rep. 2017;7(1):6877.
 31. Hofmann U, et al. Interleukin-13 deficiency 
aggravates healing and remodeling in male mice 
after experimental myocardial infarction. Circ 
Heart Fail. 2014;7(5):822–830.
 32. Zlatanova I, et al. Iron regulator hepcidin impairs 
macrophage-dependent cardiac repair after inju-
ry. Circulation. 2019;139(12):1530–1547.
 33. Zhang S, et al. Efferocytosis fuels requirements 
of fatty acid oxidation and the electron transport 
chain to polarize macrophages for tissue repair. 
Cell Metab. 2019;29(2):443–456.
 34. Shirakawa K, et al. IL (Interleukin)-10-STAT3- 
galectin-3 axis is essential for osteopontin- 
producing reparative macrophage polariza-
tion after myocardial infarction. Circulation. 
2018;138(18):2021–2035.
 35. Meyer IS, et al. The cardiac microenvironment 
uses non-canonical WNT signaling to activate 
monocytes after myocardial infarction. EMBO 
Mol Med. 2017;9(9):1279–1293.
 36. Ma Y, et al. Matrix metalloproteinase-28 
deletion exacerbates cardiac dysfunction and 
rupture after myocardial infarction in mice by 
inhibiting M2 macrophage activation. Circ Res. 
2013;112(4):675–688.
 37. Bosurgi L, et al. Macrophage function in 
tissue repair and remodeling requires 
IL-4 or IL-13 with apoptotic cells. Science. 
2017;356(6342):1072–1076.
 38. Knuhr K, et al. Schistosoma mansoni egg-re-
leased IPSE/alpha-1 dampens inflammatory 
cytokine responses via basophil interleukin  
(IL)-4 and IL-13. Front Immunol. 2018;9:2293.
 39. Meyer NH, et al. A crystallin fold in the interleu-
kin-4-inducing principle of Schistosoma man-
soni eggs (IPSE/α-1) mediates IgE binding for 
antigen-independent basophil activation. J Biol 
Chem. 2015;290(36):22111–22126.
 40. Haeberlein S, et al. Schistosome egg antigens, 
including the glycoprotein IPSE/alpha-1, trigger 
the development of regulatory B cells. PLoS  
Pathog. 2017;13(7):e1006539.
 41. Szczeklik A, et al. Serum immunoglobulin E 
response to myocardial infarction. Circulation. 
1988;77(6):1245–1249.
 42. Mohrs M, et al. Analysis of type 2 immunity in 
vivo with a bicistronic IL-4 reporter. Immunity. 
2001;15(2):303–311.
 43. McKenzie GJ, et al. Simultaneous disruption of 
interleukin (IL)-4 and IL-13 defines individual 
roles in T helper cell type 2-mediated responses.  
J Exp Med. 1999;189(10):1565–1572.
 44. Schramm G, et al. Cutting edge: IPSE/alpha-1, a 
glycoprotein from Schistosoma mansoni eggs, 
induces IgE-dependent, antigen-independent 
IL-4 production by murine basophils in vivo.  
J Immunol. 2007;178(10):6023–6027.
 45. Ohmori K, et al. IL-3 induces basophil expan-
sion in vivo by directing granulocyte-monocyte 
progenitors to differentiate into basophil lin-
eage-restricted progenitors in the bone marrow 
and by increasing the number of basophil/
mast cell progenitors in the spleen. J Immunol. 
2009;182(5):2835–2841.
 46. Bankhead P, et al. QuPath: open source software 
for digital pathology image analysis. Sci Rep. 
2017;7(1):16878.
 47. Wolf FA, et al. SCANPY: large-scale single-cell 
gene expression data analysis. Genome Biol. 
2018;19(1):15.
 48. Sharma M, et al. Regulatory T cells induce activa-
tion rather than suppression of human basophils. 
Sci Immunol. 2018;3(23):eaan0829.
